WBC
IRWD icon

West Branch Capital’s Ironwood Pharmaceuticals IRWD Stock Holding History

West Branch Capital’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-423
Closed -$4.45K – 459
2023
Q1 		$4.45K Hold
423
– – ﹤0.01% 367
2022
Q4 		$5.24K Hold
423
– – ﹤0.01% 337
2022
Q3 		$4K Hold
423
– – ﹤0.01% 367
2022
Q2 		$5K Hold
423
– – ﹤0.01% 334
2022
Q1 		$5K Hold
423
– – ﹤0.01% 355
2021
Q4 		$5K Hold
423
– – ﹤0.01% 383
2021
Q3 		$6K Hold
423
– – ﹤0.01% 342
2021
Q2 		$5K Buy
+423
New +$4.84K ﹤0.01% 376

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

West Branch Capital's IRWD Position: Q2 2023 in Review

West Branch Capital sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2023, closing a stake of 423 shares — an estimated $4.45K sold.

West Branch Capital first reported a position in IRWD in Q2 2021 and held it in 8 quarters. The position peaked at $6K in Q3 2021. 252 funds tracked by Wall St. Rank hold IRWD as of Q2 2023.

  • West Branch Capital reported no remaining Ironwood Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • West Branch Capital sold 423 Ironwood Pharmaceuticals shares in Q2 2023, an estimated $4.45K.
  • West Branch Capital first reported a position in Ironwood Pharmaceuticals in Q2 2021 and held it in 8 quarters.
  • West Branch Capital's Ironwood Pharmaceuticals position peaked at $6K in Q3 2021.
  • 252 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2023.

Based on West Branch Capital's 13F filing for Q2 2023, filed 7 Aug 2023.